DOSE OF REALITY: STUDY FINDS NEARLY THREE-QUARTERS OF BIG PHARMA’S PATENTS ON TOP-SELLING DRUGS FILED AFTER FDA APPROVAL
Analysis Showcases Egregious Scale of Big Pharma’s Patent Thickets on Blockbuster Products, Including Nearly 1,500 Patent Applications on Just Ten Drugs A new study, published in JAMA Network, examines Big Pharma’s egregious patent thickets erected around the top 10 best-selling prescription drugs in the U.S. The study found the top 10 brand name drugs in
0 CommentsComment on Facebook